BioSpace News Archive

Wize Pharma’s CEO Noam Danenberg Increases Stake in Company

Increased his ownership of common stock in Wize Pharma to 1.66% of the Company’s outstanding shares, and increased his beneficial ownership including common stock and other convertible securities to 7.70%.

April 24, 2019
·
4 min read
Business

Saint Joseph’s University Announces Dr. Angela Rowe McDonald as First Dean of the School of Health Studies and Education

Arriving from the University of North Carolina at Pembroke, McDonald brings strong experience as leader of UNC’s colleges of health sciences

April 24, 2019
·
2 min read
Dr Roebuck’s Announces Growth Capital Investment by Unilever Ventures

Following a recent and successful increase in its global market presence, the Australian-based skin care brand attracts/receives a growth capital investment led by Unilever Ventures to accelerate growth

April 24, 2019
·
2 min read
Business

US Bioservices Selected by Biocodex SAS to Exclusively Dispense DIACOMIT® (stiripentol)

DIACOMIT® is approved by the FDA in two formulations – capsules and powder for oral suspension.

April 24, 2019
·
3 min read
National Comprehensive Cancer Network Working with Health Officials in Bolivia to Improve Cancer Care

Representatives from the National Comprehensive Cancer Network® (NCCN®)—an alliance of 28 top academic cancer centers in the United States—meet today with health leaders in The Plurinational State of Bolivia to begin generating cancer treatment recommendations to fit the country’s unique needs

April 24, 2019
·
6 min read
Policy

Mesothelioma Compensation Center Now Offers a Navy Submarine Veteran with Mesothelioma or Asbestos Exposure Lung Cancer Direct Access to Famed Attorney Erik Karst to Improve the Odds for a Much Better Compensation Settlement

The Mesothelioma Compensation Center is the best branded source in the nation for US Navy Veterans who now have mesothelioma or asbestos exposure lung cancer because of exposure to asbestos on a nuclear submarine.

April 24, 2019
·
3 min read
Drug Development

Magenta Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of MGTA-145, a First-Line Stem Cell Mobilization Product Candidate

Magenta intends to develop MGTA-145 in autoimmune diseases, blood cancers and genetic diseases.

April 24, 2019
·
4 min read
Xstrahl Spotlights Full Range of X-Ray Therapy and Radiation Research Systems at ESTRO 2019

New 150kV superficial treatment system and SARRP research platform among advanced solutions showcased on Xstrahl booth at European Society for Radiotherapy & Oncology annual meeting in Milan, April 26th-29th

April 24, 2019
·
2 min read
BioMidwest

National Safety Council to Bring Memorial to the Victims of the Opioid Crisis to Albany

Exhibit honors those we’ve lost and offers hope for ending the epidemic

April 24, 2019
·
3 min read
Pharm Country

New Survey Results from Aysa: Millennials Say They Care About Skin Damage but Don’t Take the Right Precautions

In a survey of more than 1,500 U.S. millennials, 7 in 10 say skin damage is a significant concern for them.

April 24, 2019
·
3 min read